Tectonic Therapeutic, Inc. — Director's Dealing 2023

Jun 8, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AVROBIO, Inc. (AVRO)
CIK: 0001681087
Period of Report: 2023-06-06

Reporting Person: CLARK IAN T (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-06-06	Stock Option (Right to Buy)	$1.09	A	17643	Acquired	2033-06-05	Common Stock (17643)	Direct

Footnotes

F1: The option shall vest in full upon the earlier of June 6, 2024 or the date of the Issuer's 2024 Annual Meeting of Stockholders, subject to the reporting person's continued service as a director through such vesting date.